SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023 USD ($)	Oct. 01, 2022 USD ($)	Sep. 30, 2023 USD ($) segment	Oct. 01, 2022 USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments | segment			3
Net revenues before foreign exchange impact	$ 314,018	$ 297,102	$ 619,342	$ 555,901
Effect of exchange rates	(880)	(5,026)	(636)	(7,504)
Net revenues	318,183	297,485	629,515	558,943
Operating income	35,303	46,732	88,962	77,499
Effect of exchange rates	(3,091)	(51)	(478)	6,194
Amortization			14,695	16,588
Restructuring Costs	(86)	(165)
Restructuring and turnaround costs			(75)	(121)
Restructuring related costs	1,947	3,029	4,151	6,551
Digital transformation costs	3,592	0	7,297	0
Impairment of assets and PCS2 related charges	(552)	(83)	411	(267)
Intangible asset impairment	(10,419)	0	(10,419)	0
Integration and transaction costs	(1,784)	(46)	(2,899)	712
Amortization of acquired intangible assets	7,222	8,221	14,695	16,588
MDR and IVDR costs	(1,988)	(2,506)	(3,154)	(5,692)
Litigation-related charges	(5,449)	(198)	(6,507)	(394)
Gain on sale of assets	0	382	0	382
United States
Segment Reporting Information [Line Items]
Net revenues	236,345	211,724	473,418	393,720
Japan
Segment Reporting Information [Line Items]
Net revenues	15,011	15,129	26,784	29,007
Europe
Segment Reporting Information [Line Items]
Net revenues	38,666	41,850	78,053	82,307
Rest of Asia
Segment Reporting Information [Line Items]
Net revenues	27,735	27,861	49,775	52,285
Other
Segment Reporting Information [Line Items]
Net revenues	426	921	1,485	1,624
Service
Segment Reporting Information [Line Items]
Net revenues before foreign exchange impact	5,045	5,409	10,809	10,546
Net revenues	5,042	5,053	10,816	9,943
Plasma
Segment Reporting Information [Line Items]
Net revenues before foreign exchange impact	141,748	128,888	280,230	231,930
Restructuring related costs	74	108	243	748
Plasma | Plasma products and services
Segment Reporting Information [Line Items]
Net revenues	141,900	127,893	280,510	230,274
Blood Center
Segment Reporting Information [Line Items]
Net revenues before foreign exchange impact	68,912	75,652	136,218	142,225
Restructuring related costs	28	16	73	18
Blood Center | Blood Center products and services
Segment Reporting Information [Line Items]
Net revenues	68,098	73,683	135,438	139,377
Whole Blood, Blood Center | Blood Center products and services
Segment Reporting Information [Line Items]
Net revenues	14,683	19,893	34,724	39,488
Apheresis, Blood Center | Blood Center products and services
Segment Reporting Information [Line Items]
Net revenues	53,415	53,790	100,714	99,889
Hospital
Segment Reporting Information [Line Items]
Net revenues before foreign exchange impact	103,358	92,562	202,894	181,746
Restructuring related costs	98	111	147	200
Hospital | Hospital products and services
Segment Reporting Information [Line Items]
Net revenues	103,143	90,856	202,751	179,349
Hemostasis Management, Hospital | Hospital products and services
Segment Reporting Information [Line Items]
Net revenues	36,998	34,320	74,818	67,816
Vascular Closure, Hosptial | Hospital products and services
Segment Reporting Information [Line Items]
Net revenues	38,541	29,575	76,162	59,143
Other, Hopsital | Hospital products and services
Segment Reporting Information [Line Items]
Net revenues	27,604	26,961	51,771	52,390
Business Unit
Segment Reporting Information [Line Items]
Net revenues	313,141	292,432	618,699	549,000
Operating Segments
Segment Reporting Information [Line Items]
Operating income	147,183	147,418	290,107	267,643
Operating Segments | Plasma
Segment Reporting Information [Line Items]
Operating income	78,042	71,607	153,740	126,733
Operating Segments | Blood Center
Segment Reporting Information [Line Items]
Operating income	27,307	37,328	53,590	67,705
Operating Segments | Hospital
Segment Reporting Information [Line Items]
Operating income	41,834	38,483	82,777	73,205
Corporate
Segment Reporting Information [Line Items]
Operating income	$ 75,750	$ 86,769	$ 151,059	$ 168,353